Home - Products - Endocrinology/Hormones - Androgen Receptor (AR) - VPC-14228

VPC-14228

CAS No. 19983-28-9

VPC-14228( VPC 14228 | VPC14228 )

Catalog No. M27801 CAS No. 19983-28-9

VPC-14228 is a specific AR-DBD inhibitor that acts by inhibiting both Y594A and Q592A mutants.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	80	Get Quote
10MG	131	Get Quote
25MG	282	Get Quote
50MG	447	Get Quote
100MG	624	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

VPC-14228
Note

Research use only, not for human use.
Brief Description

VPC-14228 is a specific AR-DBD inhibitor that acts by inhibiting both Y594A and Q592A mutants.
Description

VPC-14228 is a specific AR-DBD inhibitor that acts by inhibiting both Y594A and Q592A mutants.
In Vitro

——
In Vivo

——
Synonyms

VPC 14228 | VPC14228
Pathway

Endocrinology/Hormones
Target

Androgen Receptor (AR)
Recptor

Indoleamine 2,3-Dioxygenase (IDO)
Research Area

——
Indication

——

Chemical Information

CAS Number

19983-28-9
Formula Weight

246.33
Molecular Formula

C13H14N2OS
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 100 mg/mL (405.96 mM)
SMILES

C1CN(CCO1)c1nc(cs1)-c1ccccc1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Shenghua Wu, et al. Indoleamine 2,3-dioxygenase inhibitor, preparation method therefor, and application. WO 2017181849 A1.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Flutamide

Flutamide is an antiandrogen drug, with its active metablolite binding at androgen receptor.
BMS-641988 B

BMS-641988 is a novel nonsteroidal androgen receptor antagonist for the treatment of prostate cancer.
ORM-15341

The active main metabolite of ODM-201, a potent wt/mutant androgen receptor (AR) inhibitor.

Sign In Join Free